CORONAVIRUS/Taiwan mulls mix-and-match trial with local COVID-19 vaccine
Taipei, July 21 (CNA) Taiwan is considering conducting a clinical trial that would test the viability of mixing a newly approved locally made COVID-19 vaccine with imported ones, the Central Epidemic Command Center (CECC) said Wednesday.
CECC specialist advisory panel convener Chang Shan-chwen (張上淳) said thought has been given to conducting a relatively small-scale clinical trial soon given that no research has been done on mixing the Taiwan-made vaccine with existing global vaccines.
If the study proved that such an approach were feasible, the Advisory Committee on Immunization Practices (ACIP) under the Ministry of Health and Welfare would officially recommend allowing that mix-and-match approach, he said.
The possibility emerged after a COVID-19 vaccine made by Taiwan-based Medigen Vaccine Biologics Corp. was granted emergency use authorization (EUA) by Taiwan's Food and Drug Administration (TFDA) on Monday, a first for a local vaccine maker.
The approval was granted even though the vaccine has only completed an expanded Phase 2 clinical trial that did not offer any data on how effectively it actually protected trial participants from getting the disease.
The EUA was granted based on the concentration of neutralizing antibodies found in trial participants compared to those found in people who received two doses of the AstraZeneca vaccine.
Chang did not say how a mix-and-match clinical trial would be structured and what it would test for, though it would likely use a similar approach of checking the level of antibodies produced by the combination of vaccines against those generated by two doses of the same vaccine.
Taiwan currently prohibits mixing doses due to the lack of clinical data on the practice's safety and efficacy.
But according to the CECC, local clinical trials on mixing the AstraZeneca vaccine with the Moderna brand have recently begun at National Taiwan University Hospital and Chang Gung Memorial Hospital, with results expected in three months.
Chang said Taiwan is doing that trial because studies done overseas have proven that mixing the AstraZeneca vaccine with the Pfizer-BioNTech vaccine is safe and effective, but no study has been done on mixing AstraZeneca with Moderna.
The unstable supply of vaccines in Taiwan has resulted in public clamor for mixing vaccines so that people can have their second shot with whatever vaccine is available.
To date, Taiwan has only received deliveries of the AstraZeneca and Moderna vaccines.
- Taiwan reports 18 new domestic COVID-19 casesTaiwan on Wednesday reported 20 new cases of COVID-19, all but two of which were domestic infections, according to the Central Epidemic Command Center (CECC).07/28/2021 02:32 PM
- Appointments open again for COVID-19 jabs; local vaccine option addedA new round of online registration and appointments for COVID-19 vaccination is now open in Taiwan to adults, who can also add one of the country's locally developed vaccines as ...07/27/2021 08:04 PM
- Taiwan open to providing local COVID vaccines to allies: MOFATaiwan is open to the possibility of providing its locally-developed COVID-19 vaccines to diplomatic allies, the Ministry of Foreign Affairs (MOFA) said Tuesday.07/27/2021 07:53 PM
Academia Sinica raises Taiwan's GDP growth for 2021 to 5.05%07/28/2021 03:14 PM
Taiwan reports 18 new domestic COVID-19 cases07/28/2021 02:32 PM
Taiwan shares close down 0.78%07/28/2021 01:59 PM
Taiwan shares under pressure across the board07/28/2021 12:10 PM
- Science & Tech
Investigation underway into cyber attack against LINE users in Taiwan07/28/2021 12:07 PM